Related Experiment Video
Updated: Sep 28, 2025

Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome
Published on: August 3, 2021
Network Analysis to Identify Multi-Omic Correlations in the Lower Airways of Children With Cystic Fibrosis
John B O'Connor1, Madison Mottlowitz1, Monica E Kruk2
1Department of Pediatrics, Division of Pulmonary and Sleep Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, United States.
Insights
Cystic fibrosis (CF) lung disease involves complex airway inflammation and infection. This study reveals unique metabolic profiles in CF airways, linking specific metabolites to bacterial communities and disease severity, offering new insights into CF progression.
Area of Science:
- Pulmonary Medicine and Microbiology
- Metabolomics and Multi-omics Analysis
Background:
- Cystic fibrosis (CF) is characterized by progressive lung disease driven by chronic airway infection and inflammation.
- The precise drivers of CF airway pathology remain incompletely understood.
- Metabolomics offers a physiological snapshot of the airway environment, aiding in the study of complex disease processes.
Purpose of the Study:
- To characterize the airway metabolome in individuals with CF (PWCF) and disease controls (DC).
- To investigate correlations between airway metabolites, microbiome composition, and markers of inflammation and bacterial burden.
- To identify novel multi-omic relationships driving CF lung disease.
Main Methods:
- Targeted liquid chromatography-mass spectrometry (LC-MS) was used to analyze 409 metabolites in bronchoalveolar lavage fluid (BALF).
- Bacterial profiling was performed using 16S sequencing, and total bacterial load (TBL) was quantified via qPCR.
- Multi-omic network analysis (SsCCNet) integrated metabolomic, microbiome, and clinical data.
Main Results:
- The CF airway metabolome showed significantly increased amino acids and decreased acylcarnitines compared to controls.
- Amino acids and acylcarnitines correlated strongly with inflammation markers (WBC, neutrophils) and bacterial load.
- Network analysis revealed specific correlations between metabolites (e.g., L-methionine-S-oxide), CF pathogens (Staphylococcus), and other bacterial taxa (Prevotella).
Conclusions:
- This study identified distinct metabolomic signatures in the airways of individuals with CF.
- Metabolomic profiles are closely linked to airway bacterial communities and inflammatory processes in CF.
- These multi-omic findings provide a foundation for further research into CF pathogenesis and potential therapeutic targets.
Abstract:
The leading cause of morbidity and mortality in cystic fibrosis (CF) is progressive lung disease secondary to chronic airway infection and inflammation; however, what drives CF airway infection and inflammation is not well understood. By providing a physiological snapshot of the airway, metabolomics can provide insight into these processes. Linking metabolomic data with microbiome data and phenotypic measures can reveal complex relationships between metabolites, lower airway bacterial communities, and disease outcomes. In this study, we characterize the airway metabolome in bronchoalveolar lavage fluid (BALF) samples from persons with CF (PWCF) and disease control (DC) subjects and use multi-omic network analysis to identify correlations with the airway microbiome. The Biocrates targeted liquid chromatography mass spectrometry (LC-MS) platform was used to measure 409 metabolomic features in BALF obtained during clinically indicated bronchoscopy. Total bacterial load (TBL) was measured using quantitative polymerase chain reaction (qPCR). The Qiagen EZ1 Advanced automated extraction platform was used to extract DNA, and bacterial profiling was performed using 16S sequencing. Differences in metabolomic features across disease groups were assessed univariately using Wilcoxon rank sum tests, and Random forest (RF) was used to identify features that discriminated across the groups. Features were compared to TBL and markers of inflammation, including white blood cell count (WBC) and percent neutrophils. Sparse supervised canonical correlation network analysis (SsCCNet) was used to assess multi-omic correlations. The CF metabolome was characterized by increased amino acids and decreased acylcarnitines. Amino acids and acylcarnitines were also among the features most strongly correlated with inflammation and bacterial burden. RF identified strong metabolomic predictors of CF status, including L-methionine-S-oxide. SsCCNet identified correlations between the metabolome and the microbiome, including correlations between a traditional CF pathogen, Staphylococcus, a group of nontraditional taxa, including Prevotella, and a subnetwork of specific metabolomic markers. In conclusion, our work identified metabolomic characteristics unique to the CF airway and uncovered multi-omic correlations that merit additional study.
More Related Videos
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...

